Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Movelat gel
1003020W0BBABAA
|
Movelat | Heparinoid | Musculoskeletal and Joint Diseases | 24,593 |
|
Heparinoid 0.3% cream
1314000H0AAAAAA
|
Heparinoid (Topical circulatory preparations) | Heparinoid | Skin | 11,430 |
|
Salicylic acid 2% / Mucopolysaccharide polysulfate 0.2% gel
1003020W0AAAAAA
|
Heparinoid (Topical Antirheumatic) | Heparinoid | Musculoskeletal and Joint Diseases | 10,422 |
|
Movelat cream
1003020W0BBAAAB
|
Movelat | Heparinoid | Musculoskeletal and Joint Diseases | 8,885 |
|
Heparinoid 0.3% gel
1314000H0AAABAB
|
Heparinoid (Topical circulatory preparations) | Heparinoid | Skin | 5,863 |
|
Hirudoid 0.3% cream
1314000H0BBAAAA
|
Hirudoid | Heparinoid | Skin | 4,687 |
|
Hirudoid 0.3% gel
1314000H0BBABAB
|
Hirudoid | Heparinoid | Skin | 3,293 |
|
Salicylic acid 2% / Mucopolysaccharide polysulfate 0.2% crm
1003020W0AAABAB
|
Heparinoid (Topical Antirheumatic) | Heparinoid | Musculoskeletal and Joint Diseases | 2,647 |
|
Movelat Relief gel
1003020W0BBADAA
|
Movelat | Heparinoid | Musculoskeletal and Joint Diseases | 966 |
|
Movelat Relief cream
1003020W0BBACAB
|
Movelat | Heparinoid | Musculoskeletal and Joint Diseases | 528 |
|
Anacal rectal ointment
0107010J0BBABAB
|
Anacal | Heparinoid | Gastro-Intestinal System | No data available |
|
Anacal suppositories
0107010J0BBAAAA
|
Anacal | Heparinoid | Gastro-Intestinal System | No data available |
|
Bruiseze 0.8% ointment
1314000H0BDAAAC
|
Bruiseze | Heparinoid | Skin | No data available |
|
Heparinoid 0.8% ointment
1314000H0AAACAC
|
Heparinoid (Topical circulatory preparations) | Heparinoid | Skin | No data available |
|
Lasonil 0.8% ointment
1314000H0BCAAAC
|
Lasonil | Heparinoid | Skin | No data available |
|
Lauromacrogol 400 5% / Heparinoid 0.2% rectal ointment
0107010J0AAABAB
|
Lauromacrogol/ Heparinoid | Heparinoid | Gastro-Intestinal System | No data available |
|
Lauromacrogol 400 50mg / Heparinoid 4mg suppositories
0107010J0AAAAAA
|
Lauromacrogol/ Heparinoid | Heparinoid | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.